BioInvent International: BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma
LUND, SE / ACCESS Newswire / March 20, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class i ...
Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today ...
Korro Reports Full Year 2024 Financial Results and Provides Business Updates
Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim readout expected in the second half of 2025 —U.S. Food and ...
Connie Britton Shares Why She Decided to Pursue Adoption as a Single Mom
Connie Britton shares why she decided to pursue adoption as a single mom. The actress adopted her son Yoby in 2011 from Ethiopia.
Connie Britton Admits Single Motherhood Was Tough. Now She's Rewriting the Narrative (Exclusive)
In Parade's exclusive cover story, the 'Zero Day' star zeroes in on her most important project to date — after all, she says, ...
Korro Bio, Inc.: KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...
The Manila Times6d
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
KRRO-110 is the first RNA editing development candidate from Korro's proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
Tuko News9d
Embu: Distressed Cancer Survivor Seeks Help to Start Business after Spending Everything on Treatment
Caroline Wawira, from Embu, is seeking financial support to restart her life and provide for her kids after spending all her ...
Targeted Oncology13d
FDA Grants Rhenium Obisbemeda Orphan Drug Status for LM in Lung Cancer
The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.
Forbes14d
Study: Vast Majority Of Single Americans Feel Burden Of ‘Singles Tax’
Commissions do not affect our editors' opinions or evaluations. If you’re among the nearly half of American adults who are single, you enjoy some freedom. But that freedom may be coupled with ...
Pharmaceutical Technology15d
Orphan drugs: How to avoid costly stock losses in Europe
Third-party logistics companies delivering orphan drugs simply don’t have sufficient ‘skin in the game’ to go above and beyond to ensure safe and timely delivery every single time. This can lead to ...
Pharmaceutical Technology15d
Realising the opportunities for growth in the European orphan drug market
The European orphan drug market is growing and is already comparable ... Unlike the US, the EU does not operate as a single standardised market. Instead, it functions as 27 individual markets—each ...